Pfizer Korea
Pfizer Korea
Seoul, South Korea2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19 | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-08-12 | NCT05890612 | |
| A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market | Pneumococcal Immunization; Safety | Recruiting | Not stated | 2026-03-12 | NCT06760208 |